In the News
Keep in touch with what is going on at Pseudomyxoma Survivor
One of the connections we have made this year is with National Voices, the coalition of charities that stands for people being in control of their health and care. National Voice has drawn our attention to a new report published by Cancer Research UK, ‘Securing a cancer workforce for the best outcomes’.
All of us here at Pseudomyxoma Survivor are really saddened by the news that Mr Fulford from the Christie has passed away. On behalf of all of us and our support group members, we pass our condolences to the team on the loss of a man that changed the lives of so many. To quote Mr Aziz, “The world is a poorer place without you, Paul”.
One of the recommendations of the Charity Commission, the body that regulates charities in the UK, is that charities work with other charities. This is extremely important to the trustees of Pseudomyxoma Survivor and key to a lot of the things we do.
Being a trustee can be very rewarding. As a trustee, you would have an opportunity to support and shape the work and strategic direction of Pseudomyxoma Survivor. You also have the chance to make a significant difference to a cause that matters to you. You...
Here at Pseudomyxoma Survivor, we’re supporting Trustees Week, running from 12th-19th November, showcasing the work trustees do and highlighting opportunities for you to get involved and make a difference. We’ll be looking at different aspects of being a trustee and we’ve asked our trustees to share their thoughts on being a trustee.
Mr Aziz is consultant colorectal surgeon at The Christie, one of Europe’s largest comprehensive cancer hospitals. At The Colorectal & Peritoneal Oncology Centre (CPOC), he specialises in complex minimally invasive (keyhole) and open surgical techniques to treat early, advanced, and recurrent tumours of the appendix, colon, rectum, and anus, including those that have spread to the lining of the abdomen (peritoneum), for which he performs cytoreductive surgery (CRS) with hyperthermic intra-peritoneal chemotherapy (HIPEC). He is also a member of the medical advisory board for Pseudomyxoma Survivor.
We are very privileged to be able to make family grants and it is thanks to the hard work of our fundraisers and donors that we have been able to do so.
I am finally getting round to informing you all of my recent visit to West Yorkshire & Harrogate Cancer Alliance. We were invited by Cancer 52 and the meeting was a great and informative one.
Currently, the Director of Research and Consultant Histopathologist at the Peritoneal Malignancy Institute in Basingstoke, Professor Carr is a leading expert in the complex pathology of pseudomyxoma peritonei (PMP). He has published over 70 papers in the peer-reviewed literature and written two textbooks for undergraduate medical students as well as several book chapters. He contributed to the 3rd and 4th editions of the World Health Organization Classification of Tumours of the Digestive System and is presently working on the 5th edition.
In 2015, I had cytoreductive surgery and HIPEC for pseudomxyoma peritonei. To thank Pseudomyxoma Survivor for all the support I was given and all the friends I have made through the charity, I’m doing the Southend 10K to raise funds for the charity. I would have been so alone and desperate without the charity and I cannot thank you enough x
Through Cancer 52, Pseudomyxoma Survivor has received a special invitation to view a multi-disciplinary diagnostic centre (MDC) in action. MDCs are being trialled here in the UK and they are set up so that patients who present with non-specific symptoms can go to a one-stop shop and have all of the tests they require to help with a diagnosis.
Pseudomyxoma Survivor representatives once again attended the bi-annual Peritoneal Surface Oncology Group International (PSOGI) conference, this time it was in Paris. The PSOGI aims to “improve the treatment and survival of peritoneal cancer patients by educating patients, by training physicians, by organizing meetings and by performing basic and clinical scientific research into peritoneal cancer and the different treatment modalities”.
The BMJ defines evidence-based medicine as:
“the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients”
It’s a constantly evolving definition and at Pseudomyxoma Survivor, we always look for scientific evidence to back up suggested treatment plans for pseudomyxoma peritonei (PMP) and appendix cancer patients.
The PERITONEAL SURFACE ONCOLOGY GROUP INTERNATIONAL conference (PSOGI2018), now in its 11th year, is almost upon us. I can't quite believe it's been two years since we attended the one in Washington DC! PSOGI is a non-profit organisation which aims to...
You can now donate your used stamps to raise much-needed funds for Pseudomyxoma Survivor. All kinds of stamps are welcome, on or off the paper.
Simply cut or carefully rip the postage stamp from the used envelope, being careful that you don’t damage the stamp, and once you have a collection pop them in an envelope
Following on from the two successful patient days held at Basingstoke Hospital and The Christie, I have been busy attending meetings with Cancer52, Eurordis, National Voices and I secured a bursary place at the Public Health England Conference in Manchester in June....
Can you help build a better understanding of patient awareness about thrombosis? New patient survey launched across Europe (including the UK).
People with cancer have a higher than normal risk of developing a blood clot – a condition known as cancer-associated thrombosis (CAT). Yet it remains under-reported, seldom discussed and often misdiagnosed.
I do an exercise class and I was having trouble keeping up and my belly was growing with no changes to my diet. In my head, I was thinking that was just signs of perimenopause and that was my new figure. Some women just have a muffin top at 44, right? I was also going to the restroom for frequent urination. I was under the care of a urologist for that at the time of my diagnosis with pseudomyxoma peritonei or PMP.
We’re very happy that we can support The Christie Colorectal & Peritoneal Oncology Centre Prehabilitation programme as a result of your fundraising and donations. This program will be looking at the use of wearable devices to get patients ‘fit for surgery’ before cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).
Huge thanks to everyone who came to speak to us at our table at the Peritoneal Tumour Patient Day at The Christie yesterday. It was lovely to see some old friends and to make lots of new ones. We were overwhelmed by the donations the charity received and so busy that...
Susan's representing Pseudomyxoma Survivor at the EURORDIS - European Rare Diseases Organisation General Assembly this week.
We got the day off to a great start at the Patients Wellbeing Day in Basingstoke by making a donation to the Peritoneal Malignancy Institute. This donation was made specifically with the help of the Leighton family and friends. Thank you!
Dr Emel Canbay is Professor and Head of Department of Surgery at Biruni University Hospital.
When someone new to the group posts, you very often see multiple members encourage them to seek an appendix cancer specialist. That was also the case when I found the support group after I was diagnosed in June of last year. I was actually misdiagnosed by my first surgical oncologist who thought it was ovarian cancer and told me that it was well behaved and that they would remove it and I would be fine…
Take your time, there’s no rush, go at your own pace and don’t feel pressured to be at a certain stage, just because someone else is. You’ll get there, in your own time, be happy still to be breathing and above ground……..
Those of us affected by pseudomyxoma peritonei and appendix cancer are amongst the millions of people affected by rare diseases around the world. As a community, we face huge challenges each and every day. Can you imagine going to multiple doctors who cannot diagnose your condition? Or being told that you aren’t a candidate for the gold standard of treatment for your disease? Or realising available treatment is too expensive? Or finding out that there are no surgeons in your country that can treat you?
I was really positive about my recovery after the major operation for pseudomyxoma peritonei (PMP). I took things really slowly and took good care of myself.
I can’t say it enough… are you dealing with a PMP specialist? If not, I would say you must.
They are the ones that have seen this stuff and the weird things it does. They can give better ideas as to what to do.
In my case, waiting seemed the best option at the time but with the specialist’s input, I chose to go ahead and now, even with the debt, the new body norms and everything, I am sooooo glad I followed his advice! He would have told me to watch and wait if in his experience there was a low risk. And I would have done it.
Just over 18 months ago, I had a full hysterectomy because they thought I had ovarian cancer….
Susan met with Ilkley MP, John Grogan, to discuss the work of Pseudomyxoma Survivor and Cancer52. Based on current data, 46 percent of cancers diagnosed are rare and less common, yet they account for 54 percent of cancer deaths.
Authors posting articles on our blog are patients and family caregivers who write their articles with the goal of sharing their experiences fellow patients and their families.
As survivors and carers, information here is from our perspective – we are not health care professionals. We are all individuals, everyone is different. We recommend that you take advice from your doctors for specific information.